BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11194707)

  • 1. Growth promoting effect of human plasma ultrafiltrate bioactive fraction (TBP) for human non-functioning pituitary adenoma cells in vitro.
    Zarković N; Hayn M; Tatzber F; Reichel H; Kor ić M; Zarković K; Plav ić V; Breskovac LJ; Klingmüller M; Paladino J
    J Endocrinol Invest; 2000 Dec; 23(11):737-43. PubMed ID: 11194707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the in vitro secretory activity of human pituitary adenomas: modification of corticotropin release from adenoma tissue explant cultures by addition of a human plasma ultrafiltrate bioactive fraction.
    Zarković N; Hayn M; Plavsić V; Zarković K; Paladino J; Hirsl N; Golubić J; Mikulandra S; Rogić D; Salzer B; Pokrić B; Schaur RJ; Tatzber F; Faulhammer H; Benko B; Dietrich W; Jurin M; Korsić M
    Eur J Clin Chem Clin Biochem; 1996 Jan; 34(1):23-30. PubMed ID: 8704030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of corticotrophin-releasing hormone, vasopressin and insulin-like growth factor-I on proliferation of and adrenocorticotrophic hormone secretion by canine corticotrophic adenoma cells in vitro.
    van Wijk PA; Rijnberk A; Croughs RJ; Meij BP; Mol JA
    Eur J Endocrinol; 1998 Mar; 138(3):309-15. PubMed ID: 9539306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
    Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
    J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
    Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC
    J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
    Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
    Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine.
    Yin D; Kondo S; Takeuchi J; Morimura T
    FEBS Lett; 1994 Feb; 339(1-2):73-5. PubMed ID: 7508871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
    Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
    World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.
    DeStephano DB; Lloyd RV; Pike AM; Wilson BS
    Am J Pathol; 1984 Sep; 116(3):464-72. PubMed ID: 6089568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of insulin-like growth factor 1 on the hormonal product and proliferation of glycoprotein-secreting human pituitary adenomas.
    Atkin SL; Landolt AM; Jeffreys RV; Hipkin L; Radcliffe J; Squire CR; White MC
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1059-66. PubMed ID: 7691862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of polypeptide growth factors by human nonfunctioning pituitary adenoma cells in culture.
    Renner U; Mojto J; Arzt E; Lange M; Stalla J; Müller OA; Stalla GK
    Neuroendocrinology; 1993 May; 57(5):825-34. PubMed ID: 8413819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
    Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
    Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tyrosine kinase activity inhibits [3H]thymidine uptake in cultured human pituitary tumor cells.
    Jones TH; Justice SK; Price A
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2143-7. PubMed ID: 9215285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
    Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.